Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 369 | 526 | 325 | 337 | 276 |
| Gross Profit | 369 | 526 | 325 | 337 | 276 |
| Operating Expenses | 19,003 | 14,789 | 13,330 | 12,013 | 10,026 |
| Operating Income | -18,634 | -14,263 | -13,005 | -11,676 | -9,750 |
| Interest Expense | 69 | 23 | 29 | 24 | 14 |
| Other Income | 3,581 | 3,072 | 1,209 | 57 | 192 |
| Pre-tax Income | -15,122 | -11,214 | -11,825 | -11,643 | -9,572 |
| Net Income Continuous | -15,122 | -11,214 | -11,825 | -22,143 | -9,572 |
| Net Income Discontinuous | N/A | -490 | -459 | -5,183 | -784 |
| Net Income | $-15,122 | $-11,704 | $-12,284 | $-24,675 | $-10,356 |
| EPS Basic Total Ops | -0.21 | -0.18 | -0.25 | -0.97 | -0.37 |
| EPS Basic Continuous Ops | -0.21 | -0.17 | -0.24 | -0.82 | -0.34 |
| EPS Basic Discontinuous Ops | N/A | -0.01 | -0.01 | -0.15 | -0.03 |
| EPS Diluted Total Ops | -0.21 | -0.18 | -0.25 | -0.97 | -0.37 |
| EPS Diluted Continuous Ops | -0.21 | -0.17 | -0.24 | -0.82 | -0.34 |
| EPS Diluted Discontinuous Ops | N/A | -0.01 | -0.01 | -0.15 | -0.03 |
| EPS Diluted Before Non-Recurring Items | -0.21 | -0.17 | -0.20 | N/A | N/A |
| EBITDA(a) | $-17,965 | $-13,691 | $-12,649 | $-11,430 | $-9,452 |